Home > News > Latest News

Latest News

2010
	Total Voting Rights and Share Capital - 15 February 2010 Full Release
	Disclosure of Significant Shareholdings - 20 January 2010 Full Release

2009
	Disclosure of Significant Shareholdings - 30 December 2009 Full Release
	Disclosure of Significant Shareholdings - 24 December 2009 Full Release
	Grant of Warrants and Share Options to Directors - 24 December 2009 Full Release
	Director/PDMR Shareholding - 24 December 2009 Full Release
	Result of GM - 21 December 2009 Full Release
	Osmetech Names John Bellano Sr. Vice President Commercial Operations - 9 December 2009 Full Release
	Proposed Placing of 479,800,841 New Ordinary Shares - 1 December 2009 Full Release
	Change in Details of a Director - 24 November 2009 Full Release
	Grant of Warrants and Share Options to Directors - 8 October 2009 Full Release
	Osmetech and Fisher Agree to Terminate US Distribution Agreement - 24 September 2009 Full Release
	Disclosure of Significant Shareholdings - 24 September 2009 Full Release
	Interim results for the 6 months ended 30 June 2009 - 17 September 2009 Full Release
	Disclosure of Significant Shareholdings - 7 September 2009 Full Release
	Board Changes - 1 September 2009 Full Release
	Osmetech a Finalist for 2009 ABBY Award - 25 August 2009 Full Release
	Disclosure of Significant Shareholdings - 17 August 2009 Full Release
	Osmetech’s eSensor XT-8 System wins ‘R&D 100 Award’ - 30 July 2009 Full Release
	Disclosure of Significant Shareholdings - 20 July 2009 Full Release
	Board Change - 17 July 2009 Full Release
	Disclosure of Significant Shareholdings - 14 July 2009 Full Release
	FDA clears Osmetech’s Cystic Fibrosis Genotyping Test - 9 July 2009 Full Release
	Disclosure of Significant Shareholdings - 1 July 2009 Full Release
	Christopher Gleeson Appointed Chairman - 1 July 2009 Full Release
	£5.5m placing of new ordinary shares - 25 June 2009 Full Release
	Osmetech’s exclusive Warfarin CYP4F2 biomarker included in leading warfarindosing.org algorithm - 8 June 2009 Full Release
	Disclosure of Significant Shareholdings - 3 June 2009 Full Release
	Disclosure of Significant Shareholdings - 26 May 2009 Full Release
	Disclosure of Significant Shareholdings - 22 May 2009 Full Release
	Disclosure of Significant Shareholdings - 18 May 2009 Full Release
	Osmetech’s eSensor XT-8 platform wins Medical Design Excellence Award - 14 May 2009 Full Release
	Osmetech chosen as principal supplier for a major clinical trial - 12 May 2009 Full Release
	Osmetech submits swine flu test to the FDA - 11 May 2009 Full Release
	Results of AGM - 5 May 2009 Full Release
	Osmetech and Fisher HealthCare sign U.S. distribution agreement - 1 April 2009 Full Release
	Osmetech plc preliminary results for the 12 months ended 31 December 2008 - 1 April 2009 Full Release
	Disclosure of Significant Shareholdings - 23 January 2009 Full Release
	Disclosure of Significant Shareholdings - 8 January 2009 Full Release
	Extended warfarin sensitivity test submitted for FDA approval - 6 January 2009 Full Release
	Disclosure of Significant Shareholdings - 5 January 2009 Full Release

2008
	Changes in Board - 31 December 2008 Full Release
	Result of EGM - 22 December 2008 Full Release
	Disclosure of Significant Shareholdings - 17 December 2008 Full Release
	Disclosure of Significant Shareholdings - 15 December 2008 Full Release
	Disclosure of Significant Shareholdings - 10 December 2008 Full Release
	PROPOSED PLACING OF £6.9 MILLION - 4 December 2008 Full Release
	Clinical trials commence for extended warfarin sensitivity test - 10 November 2008 Full Release
	CYP450 2C9 test launch - 4 November 2008 Full Release
	Warfarin Sensitivity study results Update on proposed issue of American Depositary Shares - 31 October 2008 Full Release
	RESULTS OF EXTRAORDINARY GENERAL MEETING - 1 October 2008 Full Release
	Interim results for the 6 months ended 30 June 2008 - 25 September 2008 Full Release
	Osmetech and QIAGEN sign development and supply agreement for QIAplex-based respiratory viral molecular test - 22 September 2008 Full Release
	SEC Registration Statement F-1 - 12 September 2008 Full Release
	Proposed issue of American Depositary Shares and new Ordinary Shares and proposed listing of American Depositary Shares on NASDAQ Global Market - 12 September 2008 Full Release Full Circular
	Board Changes - 12 August 2008 Full Release
	Osmetech Says FDA Clearance of Its Warfarin Test Will Help Expand Menu, Installed Base - 22 July 2008 Full Release
	Osmetech announces first shipments of new eSensor® XT-8 platform and Warfarin Sensitivity Test - 30 July 2008 Full Release
	FDA clears Osmetech’s Warfarin Sensitivity Test and new eSensor® XT-8 platform - 21 July 2008 Full Release
	Change of Adviser - 21 July 2008 Full Release
	Results of AGM - 14 May 2008 Full Release
	Osmetech plc preliminary results for the 12 months ended 31 December 2007 - 28 March 2008 Full Release
	Osmetech licenses Roche polymerase technology - 12 March 2008 Full Release
	Marshfield Clinic Discovers Gene Variant Which Will Significantly Enhance the Accuracy of Molecular Tests for Warfarin Metabolism - 12 February 2008 Full Release
	Disclosure of Significant Shareholdings - 11 January 2008 Full Release
	Warfarin test submitted for FDA approval - 7 January 2008 Full Release

2007
	Disclosure of significant shareholding -12 December 2007 Full Release
	Disclosure of significant shareholding - 26 November 2007 Full Release
	Disclosure of significant shareholding - 19 November 2007 Full Release
	Disclosure of significant shareholding - 12 November 2007 Full Release
	Commencement of clinical trials for warfarin - 12 November 2007 Full Release
	Osmetech Licenses Warfarin Biomarker from Marshfield Clinic - 2 November 2007 Full Release
	Disclosure of Significant Shareholdings - 8 November 2007 Full Release
	Disclosure of Significant Shareholdings - 7 November 2007 Full Release
	Disclosure of Significant Shareholdings - 22 October 2007 Full Release
	Osmetech To Be Awarded New Electrochemical Detection Patents - 4 October 2007 Full Release
	Disclosure of Significant Shareholdings - 3 October 2007 Full Release
	Disclosure of Significant Shareholdings - 27 September 2007 Full Release
	Interim Results for the 6 months to 30 June 2007 - 27 September 2007 Full Release
	U.S. Food and Drug Administration (“FDA“) update labelling for warfarin - 17 August 2007 Full Release
	Osmetech licenses SAM technology to Minerva Biotechnologies - 18 June 2007 Full Release
	Osmetech licenses Roche Hot Start Polymerase Technology - 5 June 2007 Full Release
	Osmetech plc – AGM Statement - 3 May 2007 Full Release
	Annual Report and Accounts 2006 - 3 April 2007 Full Release
	Preliminary Results for the year ended 31 December 2006 - 20 March 2007 Full Release
	Osmetech plc - Cancellation of Warrants - 20 March 2007 Full Release
	Osmetech licenses VKOR pharmacogenetic marker for warfarin dosage management from University of Washington - 09 March 2007 Full Release
	Appointment of Director - 14 February 2007 Full Release
	Completion of US$ 44.9 million sale of Critical Care Division to IDEXX - 01 February 2007 Full Release
	Molecular Diagnostics supply agreement - 16 January 2007 Full Release
	Osmetech and EPIDAUROS establish strategic partnership to develop pharmaceutical companion diagnostics and novel molecular diagnostic products - 09 January 2007 Full Release

2006
	Disposal of Critical Care Division - 18 December 2006 Full Release
	Osmetech increases patent holdings - 15 November 2006 Full Release
	Osmetech licenses pharmacogenetic marker for P450-CYP2D6 from EPIDAUROS - 16 October 2006 Full Release
	Osmetech licenses self-assembling monolayer (SAM) nanotechnology to Evanston, Illinois-based Ohmx Corporation - 10 October 2006 Full Release
	Interim Results for the 6 months to 30 June 2006 - 13 September 2006 Full Release
	Trading Update - 10 July 2006 Full Release
	Trading update and Placing of 71,000,000 new ordinary shares - 16 June 2006 Full Release Full Circular
	AGM Statement - 3 May 2006 Full Release
	Osmetech Annual Report & Accounts for the 8 months ended 31 December 2005 - 3 April 2006 Investors - Company Reports
	Launch of eSensor Cystic Fibrosis Carrier Detection System - 28 March 2006 Full Release
	Preliminary Results for the 8 months to 31st December 2005 - 21 March 2006 Investors - Company Reports
	FDA clearance for cystic fibrosis molecular diagnostics test - 24 January 2006 Full Release
	Appointment of Nominated Advisor and Broker - 20 January 2006 Full Release
	Trading Update - 19 January 2006 Full Release

2005
	Osmetech Annual Report and Accounts for 2005 - 8 September 2005 Investors - Company Reports
	Preliminary Results for the 12 months to 30th April 2005 - 2 September 2005 Full Release
	Osmetech appoints head of newly acquired CMS - 4 August 2005 Full Release
	New OPTI products update - 1 August 2005 Full Release
	CMS Cystic Fibrosis clinical research poster - 14 July 2005 Full Document (pdf)
	Proposed acquisition of Clinical Micro Sensors, Inc. ("CMS") from Motorola, Inc., and Placing - 1 July 2005 Full Release Full Circular
	Vial Technology License to Roche Diagnostics - 27 April 2005 Full Release
	Interim Report for the 6 months to 31st October 2004 - 27 January 2005 Full Release